El equipo desarrollará una terapia basada en ARN, diseñada para inhibir específicamente la molécula de ARN largo no codificante (lncRNA). El objetivo es frenar el crecimiento del tumor y abrir nue...
Read more
Through the European project Disc4All, led by UPF researcher Jérôme Noailly, tools based on AI and computer simulation have been created to identify and treat spinal degeneration. The European Comm...
Read more
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to a new gene therapy for Amyotrophic Lateral Sclerosis (ALS) developed at the Universitat Autònoma de Barcelona and li...
Read more
Highlight Therapeutics and CNIO are collaborating to proof BO-112 effectiveness against the most common form of skin cancer, which is linked to sun exposure and is on the rise.
Read more
The deeptech company DevsHealth, a member of Catalonia.health, and the Foundation for the Research of Neglected Diseases (FNDR), based in India, announce the identification of DHFLV_003B, the first an...
Read more
New purity offering, off-target analysis services and additional solutions help to bridge the gap from discovery research to clinical translation and advance CRISPR-based therapies
Read more
Sugieren que el NT-proBNP constituye una herramienta potente, accesible y económica para la estratificación del riesgo en pacientes con infarto agudo de miocardio con elevación del segmento ST (IAM...
Read more
Human eggs are some of the most patient cells in the body, lying dormant for decades until needed. A study published today in The EMBO Journal shows that the cells deliberately slow the activity of th...
Read more
Researchers have identified genomic alterations associated with treatment response in HER2-positive breast cancer.
Read more
Amino acids play a fundamental role in regulating how cells respond to drugs. These molecules, which form proteins, act like bricks that communicate with each other within a structure. In this way, th...
Read more
After receiving chemotherapy and radiotherapy, the patient also began immunotherapy with immune checkpoint inhibitors (ICI), a treatment that boosts the ability of lymphocytes to recognise and combat ...
Read more
The research, published in the journal Nature Communications, identifies an area of the abdomen as a hiding place for the bacteria, which could explain why the disease becomes chronic.
Read more
La mejor actitud que podemos adoptar es la de trat...
The research team observed changes in head circumf...
AtCDF3 gene induced greater production of sugars a...
En nuestro post hablamos sobre este interesante tipo de célula del...
Telum Therapeutics, a biotechnology company leveraging proprietary met...
